Study number 0779-180
New Group Added!
Dates
Aug 25 2025-Sep 19 2025
Location
Madison, Wisconsin
Age
18-55
Gender
Males and Females
Smoker
No
Compensation
$8,110
Group
C3
Study Details
The purpose of this study is to assess the effects that itraconazole, rifampin, esomeprazole and famotidine have on how the study drug is absorbed, broken down and eliminated by your body. In addition, the safety and tolerability of the study drug taken in combination with one of the four co-medications will be assessed.
Fortrea Madison, WI is currently recruiting Healthy Adults, ages 18-55 with a BMI between 18-32
Body Mass Index
- Participants must have a BMI of:
- 18-32
Smoking criteria
- Smoking is not allowed within 1 month prior to screening
Screening procedures
- Screening procedures for this study may include:
- Vitals
- Physical examination
- Electrocardiogram (ECG)
- Collection of blood samples
- Drug and Alcohol testing
Additional Details
Cohort 3:
Check-in: Aug 25
Check-out: Sep 8
Call: Sep 19